MedTrace Logo

Quality of Life After Oesophageal or Gastric Cancer Surgery

NCT01657175 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 82

Last updated 2017-04-12

No results posted yet for this study

Summary

This study aim to assess quality of life of patients 0-5 years after oesophageal or gastric cancer surgery and to develop and test an information and support program aiming to enhance the patients quality of life (QOL) after surgery. The project contains 3 part-studies focusing on the patients life after surgery.

Data will be collected through focus group interviews and a randomized controlled trial (RCT) study.

Conditions

Interventions

OTHER

Supportive care

The patients will be randomized to control or supportive care groups. The control group will be given "care as usual" wich include clinical follow-ups at the surgical department. The supportive care group get in addition to the clinical follow-ups a supportive care programme including: * Discharge information about surgery and life after surgery together with their relatives. * Active telephone contacts 1/week th first month the 2/month up to six month after discharge by a specialized nurs. * Open telephone line were the patients can call the nursed ruing daytime. Discharge: approximately 2-4 weeks after surgery

Sponsors & Collaborators

  • Skane University Hospital

    collaborator OTHER

  • Region Skane

    lead OTHER

Principal Investigators

  • Jan Johansson, MD PHD · Department of surgery, Skåne university hospital

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2009-01-31
Primary Completion
2013-12-31
Completion
2014-09-30

Countries

  • Sweden

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01657175 on ClinicalTrials.gov